Estimate prognosis in Hodgkin's disease.
The Hasenclever International Prognostic Score (IPS) was designed to predict five-year freedom from progression of Hodgkin's disease. With each additional adverse prognostic factor, the predicted rate is reduced by approximately 8%. The score was developed and validated based on a set of patients being treated in the 1980s with regimens including ABVD, MOPP and ABVD, and similar hybrid regimens. Treatment variations did not appear to affect the validity of the prognostic score.
Hasenclever D, Diehl V
The Hasenclever International Prognostic Score (IPS) was designed to predict five-year freedom from progression of Hodgkin's disease. With each additional adverse prognostic factor, the predicted rate is reduced by approximately 8%. The score was developed and validated based on a set of patients being treated in the 1980s with regimens including ABVD, MOPP and ABVD, and similar hybrid regimens. Treatment variations did not appear to affect the validity of the prognostic score.
Hasenclever D, Diehl V
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
